Empresas y finanzas

Kraton Polymers Opens New Doors for TPE-S Compounds in High Temperature Applications



    Kraton Polymers LLC (Kraton) a leading global engineered polymer
    company, announces the commercialization of Kraton G1633(R) polymer
    and the creation of new opportunities for TPE-S (styrenic
    thermoplastic elastomer) compounds in high temperature, high
    performance applications.

    Kraton research has developed a new solution that allows customers
    to match or outperform the performance of TPV (thermoplastic
    vulcanizate) material when using Kraton G1633 with the right
    combination of Polyolefin blends.

    The innovation allows the automotive, medical, construction and
    heavy-industrial sectors to achieve best in class performances and
    long term durability combined with high quality aesthetics and lighter
    weight. Kraton G1633 improves the compression set and stress
    relaxation of TPE-S compounds at temperatures over 70 degrees Celsius.
    It allows the production of TPE-S compounds with a broad hardness
    range, excellent oil extendibility, very good processability in both
    extruded and injection molded applications, recyclability and
    extensive bonding possibilities when compared to alternative material
    solutions.

    Kevin M. Fogarty, Executive VP Kraton Polymers, comments: "Kraton
    G1633 polymer provides a good example of how Kraton Polymers focuses
    its innovation on advancing application possibilities for customers.
    Its excellent combination of physical, hardness and processing
    properties makes it the ideal solution for maximising the performance
    of TPE-S compounds when high temperature performance is required. The
    recent success of TPE-S for weatherseals in the European automotive
    sector demonstrates the potential of TPE-S compounds to the worldwide
    industry."

    Kraton G1633 is acceptable for use under FDA and European
    regulations for direct food contact applications, and meets
    requirements under the United States Pharmacopoeia (USP) Class VI
    Biological Reactivity Tests.

    For more information on Kraton G1633 polymers visit our website at
    www.Kraton.com or for direct enquiries customers should contact their
    sales representative or Kraton market development manager, for Europe
    Emmanuel.Colchen@kraton.com, for US Bing.Yang@kraton.com, for Asia
    Norio.masuko@kraton.com

    About Kraton

    Kraton is a leading global engineered polymer company and, we
    believe, the world´s largest producer of styrenic block copolymers
    (SBCs), a family of products whose chemistry was pioneered by us over
    forty years ago. SBCs are highly-engineered thermoplastic elastomers,
    which enhance the performance of numerous products by delivering a
    variety of attributes, including greater flexibility, resilience,
    strength, durability and processability. Kraton polymers are used in a
    wide range of applications including adhesives, coatings, consumer and
    personal care products, sealants, lubricants, medical, packaging,
    automotive, paving, roofing, and footwear products. Kraton has the
    leading position in nearly all of its core markets and is the only
    producer of SBCs with global manufacturing capability. Its production
    facilities are located in the United States, Germany, France, The
    Netherlands, Brazil, and Japan.

    Kraton, the Kraton logo and design, and "Giving Innovators their
    Edge" tagline are trademarks of Kraton Polymers LLC.

    Forward Looking Statements

    This press release includes "forward-looking statements" which are
    statements other than statements of historical fact and are often
    characterized by the use of words such as "believes," "expects,"
    "estimates," "projects," "may," "will," "intends," "plans" or
    "anticipates," or by discussions of strategy, plans or intentions. All
    forward-looking statements in this press release are made based on
    management´s current expectations and estimates, which involve risks,
    uncertainties and other factors that could cause results to differ
    materially from those expressed in forward-looking statements. Readers
    are cautioned not to place undue reliance on forward-looking
    statements. We assume no obligation to update such information.